Search
Deep Intelligent Pharma Completes Near $50 Million Series D Funding
2025-12-11 /
Read about 0 minute
Author：小编
On December 11, Deep Intelligent Pharma, an AI-driven drug R&D platform, announced the completion of its Series D funding round, raising nearly $50 million. The round was led by CDH Invested Development, with existing investors Xinding Capital and Sequoia Capital China participating in follow-on investments. Index Capital served as the exclusive financial advisor.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
